Becton Dickinson and Company (BDX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Becton Dickinson and Company (BDX) is Neutral.

The composite score behind that read is +0.06, weighing +0.15 of bullish evidence against -0.18 bearish.

Becton Dickinson and Company last closed at $183.75, +0.55% on the session.

Against the IVW growth benchmark the position is -0.25% over the forecast window.

The read is built from 15 underlying insights — 4 bullish and 11 bearish.

Agreement across those insights is 73%.

Becton Dickinson and Company has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Becton Dickinson and Company in the 18th percentile on valuation and the 48th percentile on return on equity, where 100 is best.

Becton Dickinson and Company is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $49.78B.

StockMap tracks Becton Dickinson and Company as the 6th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Becton Dickinson and Company ranks 25th of 140 in the group, against a group median of -0.03.